ALPL and metastatic prostate carcinoma: Considerable advances have been made to identify small-molecule inhibitors of TNAP for the treatment of diseases associated with arterial medial calcification (Narisawa et al, 2007; Sidique et al, 2009), and our results suggest that these inhibitors would be of interest to evaluate in the setting of metastatic prostate cancer.